Can allergic keratitis be treated with intravenous infusion?

If keratitis is not treated properly, it increases the risk of corneal perforation and corneal ulcers, potentially leading to vision loss or even blindness. So, can allergic keratitis be treated with intravenous (IV) infusion?

Can allergic keratitis be treated with IV infusion?

Whether a patient with keratitis requires IV therapy depends on the severity and nature of their condition. For mild cases, IV treatment is generally unnecessary; instead, topical antibiotic eye drops and/or oral antibiotics—prescribed and monitored by a physician—can effectively control the disease. In severe cases where oral medications prove insufficient, intravenous antibiotics may be administered to rapidly suppress local inflammation. Keratitis has multiple etiologies: IV antibiotics may yield better results for bacterial or viral keratitis, but are less effective for fungal keratitis, as few antifungal agents are available for systemic use. For fungal keratitis, topical antifungal agents—selected based on sensitivity testing—are typically preferred. Patients should rest adequately, avoid staying up late, maintain good ocular hygiene, and refrain from touching their eyes with unwashed hands.

When keratitis occurs, identifying its underlying cause—whether bacterial, viral, or associated with other ocular complications—is essential. For example, severe keratitis may trigger intraocular inflammation, such as iridocyclitis, which represents a serious clinical condition. Conversely, if keratitis results solely from prolonged contact lens wear causing corneal epithelial shedding and superficial inflammation, systemic IV therapy is unnecessary. In clinical practice, systemic IV infusions are rarely used for conjunctivitis or keratitis. Most such inflammatory conditions respond well to localized treatments—including topical medications and eye drops—unless complicated by severe intraocular infection. In such rare instances, IV therapy may be considered based on the specific pathogen (bacterial or viral) identified. In summary, systemic IV infusion is seldom indicated for isolated ocular surface inflammation.

Patients are advised to avoid excessive eye strain in daily life—particularly prolonged screen time—and to take proactive measures to protect their eyes. We hope this information proves helpful.